Ekso Bionics® To Showcase First FDA Cleared Exoskeleton Approved for Use with Stroke Patients at 9th World Congress for NeuroRehabilitation (WCNR) May 10, 2016
Ekso Bionics announces 1-for-7 Reverse Stock Split in preparation for Proposed Uplisting to NASDAQ May 4, 2016
